BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31361906)

  • 1. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases.
    Meer S; Perner Y; Willem P
    J Oral Pathol Med; 2022 Feb; 51(2):146-151. PubMed ID: 34910327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
    Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
    Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmablastic lymphoma: An update.
    Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?
    Boy SC; van Heerden MB; Raubenheimer EJ; van Heerden WF
    J Oral Pathol Med; 2010 May; 39(5):435-9. PubMed ID: 20537055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmablastic lymphomas show restricted EBV latency profile and
    Ramburan A; Kriel R; Govender D
    Leuk Lymphoma; 2022 Feb; 63(2):370-376. PubMed ID: 34612761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.
    Vega F; Chang CC; Medeiros LJ; Udden MM; Cho-Vega JH; Lau CC; Finch CJ; Vilchez RA; McGregor D; Jorgensen JL
    Mod Pathol; 2005 Jun; 18(6):806-15. PubMed ID: 15578069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
    Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
    Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea.
    Kim JE; Kim YA; Kim WY; Kim CW; Ko YH; Lee GK; Choi SJ; Jeon YK
    Leuk Lymphoma; 2009 Apr; 50(4):582-7. PubMed ID: 19373656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV positive mucocutaneous ulcer with plasmacytic/plasmablastic differentiation and MYC rearrangement: a diagnostic challenge and a mimic of plasmablastic lymphoma.
    Chen BJ; Chiang WF; Chen TS; Kao HJ; Chuang SS
    Pathology; 2019 Oct; 51(6):648-650. PubMed ID: 31472984
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
    Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E
    Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
    Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
    Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral plasmablastic lymphoma: A clinicopathological study of 113 cases.
    Fonseca FP; Robinson L; van Heerden MB; van Heerden WFP
    J Oral Pathol Med; 2021 Jul; 50(6):594-602. PubMed ID: 34091967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.
    Laurent C; Fabiani B; Do C; Tchernonog E; Cartron G; Gravelle P; Amara N; Malot S; Palisoc MM; Copie-Bergman C; Glehen AT; Copin MC; Brousset P; Pittaluga S; Jaffe ES; Coppo P
    Haematologica; 2016 Aug; 101(8):976-84. PubMed ID: 27175027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
    Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
    J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.
    Fukuo Y; Shibuya T; Ashizawa K; Ito K; Saeki M; Fukushima H; Takahashi M; Nomura K; Okahara K; Haga K; Akazawa Y; Nomura O; Ogura K; Okubo H; Nagahara A
    Intern Med; 2021 Sep; 60(18):2947-2952. PubMed ID: 33776007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].
    Wu WN; Xiang CX; Ma DS; Liu GZ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):506-511. PubMed ID: 35673721
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
    Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
    Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.